Funder
Canadian Institutes for Health Research
Genome Canada
Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Economics and Econometrics,General Medicine
Reference162 articles.
1. Zelmer JL. The economic burden of end-stage renal disease in Canada. Kidney Int. 2007;72(9):1122–9. https://doi.org/10.1038/sj.ki.5002459 (published Online First: 2007/08/19).
2. Liyanage T, Ninomiya T, Jha V, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975–82. https://doi.org/10.1016/S0140-6736(14)61601-9 (published Online First: 20150313).
3. Canadian Organ Replacement Register. Canadian Institute for Health Information. Treatment of End-Stage Organ Failure in Canada, 2010 to 2019 2020. https://www.cihi.ca/en/organ-replacement-in-canada-corr-annual-statistics-2020. Accessed 21 Apr 2022.
4. Sussell J, Silverstein AR, Goutam P, et al. The economic burden of kidney graft failure in the United States. Am J Transplant. 2020;20(5):1323–33. https://doi.org/10.1111/ajt.15750 (published Online First: 20200204).
5. Tonelli M, Wiebe N, Knoll G, et al. Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. Am J Transplant. 2011;11(10):2093–109. https://doi.org/10.1111/j.1600-6143.2011.03686.x (published Online First: 20110830).